EXPANDING YOUR REACH

A BRIDGE TO CHINA

To complement your drug and MD development and shorten the time to market in China, Opera acts as a bridge to China.

Our regulatory experts have years of experience with the NMPA and are familiar with the subtle differences in local regulatory requirements. They can provide you with feasible strategies and act as liaison with various regulatory agencies, both on technical and regulatory issues.

A BRIEF INTRODUCTION OF TIGERMED

A global CRO with Chinese origins that is committed to supporting her clients in their clinical development in the best possible way.

Since Tigermed's inception in 2004, the company has always embraced new technologies and partnerships to accelerate product development and generate the clinical evidence its clients require to demonstrate real-world value.

2000+
Clinical Trials

5300+
Colleagues

300+
Innovative Drug Projects

130+
Service Locations

OFFERING SUPPORT THROUGHOUT THE PRODUCT LIFECYCLE

Tigermed’s core strengths lie in providing professional clinical development, R&D services, and value-adding solutions to support our life sciences clients, throughout the product lifecycle.​

  • Clinical Operations

  • Regulatory Affairs

  • Integrated Technology

  • Biometrics

  • Real-World Data

  • Medical Devices

Navigating China's Market

Thanks to our partnership with Tigermed, we have all the resources to support biotech, pharmaceutical, and medical companies to enter the Chinese market.

NMPA Interaction

Our regulatory experts have years of experiences with the NMPA, China's Health Authority, and are familiar with the differences in local regulatory requirements.

Regulatory Strategy

Known as the 'Innovative CRO' in China, Tigermed has a history of providing the up-to-date intelligence that is essential for any regulatory strategy to enter the Chinese pharmaceutical market.

Local Expertise, Global Reach

The Tigermed Group has successfully supported thousands of companies in local trials and global projects and enabled them to provide solutions for unmet patient needs.

Clinical Trials in China

Tigermed's team has covered 57 cities across China with over 1000 professionals. Together, they have performed over 700 trials in more than 700 hospitals.

Medical Translations

Tigermed's team has covered 57 cities across China with over 1000 professionals. Together, they have performed over 700 trials in more than 700 hospitals.

OTHER TIGERMED

SOLUTIONS

Do you want to know more about China-related matters regarding Clinical Trials, Regulatory Affairs, Product Development, and the Chinese market landscape? Set up a call with one of our experts.

  • LinkedIn - White Circle

Solutions

Clinical Trials

Bridge to China

Medical Devices

Opera

About

Insights

Privacy

Sitemap

Address

Strada Cozia 10, Timișoara 300425, Romania

Contact

       info@operacro.com

       +40.256.200.353